Detection of Interleukin 2 in the Urine of Patients with Superficial Bladder Tumors after Treatment with Intravesical BCG-Reference-Cited by-同舟云学术

Detection of Interleukin 2 in the Urine of Patients with Superficial Bladder Tumors after Treatment with Intravesical BCG

Published:1986-10 Issue:4 Volume:136 Page:970-974
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Haaff Eric O.¹,Catalona William J.¹,Ratliff Timothy L.¹

Affiliation:

1. From the Washington University School of Medicine, Jewish Hospital of St. Louis, St. Louis, Missouri

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference24 articles.

1. Bladder cancer immunotherapy;Lamm;J. Urol.,1982

2. Experience with Bacillus Calmette-Guerin in patients with superficial bladder carcinoma;Brosman;J. Urol.,1982

3. Lamm, D. L., Crawford, E. D., Montie, F. E., Scardino, P. T., Stanisic, T. H., Grossman, H. B. and Sullivan, F. W.: BCG vs adriamycin in the treatment of transitional cell carcinoma in situ: a southwest oncology group study. Proc. Am. Urol Assoc., p. 184A, 1985.

4. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guerin strain of Mycobacterium bovis;Bartlett;J. Natl. Cancer Inst.,1972

5. Kelley, D. R., Haaff, E. O., Becich, M., Lage, J., Bauer, W. C., Dresner, S. M., Catalona, W. J. and Ratliff, T. L.: Prognostic value of PPD skin test and granuloma formation in patients treated with intravesical BCG. J. Urol., In Press.

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy;Bladder Cancer;2018

2. Immunotherapy in Bladder Cancer;Current Molecular Pharmacology;2016-09-05

3. Natural product derived immune-regulatory agents;International Immunopharmacology;2016-08

4. BCG;Immunotherapy of Cancer;2016

5. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette–Guérin;Future Oncology;2014-06